Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

iSTAR Medical receives U.S. FDA approval to start pivotal trial for MINIject in glaucoma patients

prnasiaJuly 15, 2021

Tag: MIGS , Istar , glaucoma , MINIjectTM

PharmaSources Customer Service